Recall record at a glance
| Official record | F-2383-2017 |
|---|---|
| Category | Food Recalls |
| Classification | Class II |
| FDA record status | Terminated |
| Recalling firm | Threshold Enterprises Ltd |
| Report date | Jul 19, 2017 |
| Recall initiation date | Sep 11, 2015 |
| Quantity | 9,361 units |
| Location | Scotts Valley, CA, United States |
Official product description
Source Naturals Renewal Antioxidant Tablet: 10 Count Sample Pack, 30 Count, 60 Count, & 120 Count per bottle; Ingredient: Maltodextrin, Cellulose (Capsules, Silica and magnesium stearate; 30 count Bottle - Product SN1750: 60 count Bottle - Product SN1751; 120 count Bottle - Product SN1752; 10 Count Sample Packs - Product SN5024. Manufactured for Source Naturals, Santa Cruz, CA
Why the product was recalled
Dietary supplements contain low levels of undeclared boron
Distribution information
Nationwide only.
How to read the classification
FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Telephone.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.